A Case of Malignant Pheochromocytoma Treated with 131I-Metaiodobenzylguanidine and Alpha-Methyl-p-Tyrosine

5Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

A 47-year-old man had surgery for paraaortic paraganglioma in 1980 and 1985. In 1987, his urinary excretion of catecholamines and metabolites was extremely high. Scintigraphy with 131I-metaiodobenzylguanidine (MIBG) showed multiple bone and liver metastases. He was treated twice with infusions of 3.7 GBq of 131I-MIBG. After the first treatment, he had transient hypertension and pain in the back and right leg. Subsequent 131I-MIBG scintigraphy showed that the number of metastatic tumors had decreased. The second treatment was less effective. Excess catecholamines were treated with alpha-methyl-p-tyrosine (MPT), a catecholamine synthesis inhibitor, at doses between 250 and 2000 mg/day, which significantly decreased urinary NE excretion. This is the first case treated with 131I-MIBG in Japan. © 1990, The Japanese Society of Internal Medicine. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Nakagami, Y., Nomura, K., Miko, N., Tsushima, T., Demura, H., & Kusakabe, K. (1990). A Case of Malignant Pheochromocytoma Treated with 131I-Metaiodobenzylguanidine and Alpha-Methyl-p-Tyrosine. Japanese Journal of Medicine, 29(3), 329–333. https://doi.org/10.2169/internalmedicine1962.29.329

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free